escitalopram oxalate

This page contains recent news articles, when available, and an overview of escitalopram oxalate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

escitalopram oxalate
(when available)

Pharmacology and use:
Escitalopram is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety. The antidepressant, antiobsessive-compulsive, and antibulimic actions of escitalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. In vitro studies show that escitalopram is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake. Escitalopram has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of escitalopram was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Escitalopram does not inhibit monoamine oxidase. For the treatment of major depressive disorder and Generalized Anxiety Disorder (GAD).

Mechanism Of Action:
The antidepressant, antiobsessive-compulsive, and antibulimic actions of escitalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. Escitalopram blocks the reuptake of serotonin at the serotonin reuptake pump of the neuronal membrane, enhancing the actions of serotonin on 5HT1A autoreceptors. SSRIs bind with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs.

News Articles on Escitalopram

Wife and child sip tainted earl grey tea served by veteran firefighter  -  ‎Nov 4, 2009‎
Lexapro (escitalopram oxalate) is a once a day medication for major depressive disorder and generalized anxiety disorder, available by prescription only. ... Examiner.com

Forest Laboratories, Inc. Reports Fiscal Second Quarter 2010 Earnings Per ...  -  ‎Oct 20, 2009‎
Sales of Lexapro (escitalopram oxalate), an SSRI for the initial and maintenance treatment of major depressive disorder in adults and adolescents and ... Reuters

Lupin gets US FDA approval for Escitalopram Oxalate tablets  -  Jun 16, 2008
MUMBAI (Thomson Financial) - India's Lupin Ltd. said its US subsidiary Lupin Pharmaceutical Inc. (LPI) has received tentative abbreviated new drug ... Forbes

Teva to Sell Lexapro Tablets  -  May 23, 2006
Teva's AB-rated escitalopram oxalate tablets are used for the treatment of depression. The Israel-based company is currently in patent litigation concerning ... TheStreet.com - TheStreet.com (subscription)

Ivax denies rumour it is in talks on patent dispute settlement with...  -  Oct 6, 2005
Ivax said it is not currently in discussions with Forest Labs on a settlement in the patent case over escitalopram oxalate, the generic equivalent of ... Forbes

Cadila gets US FDA approval  -  May 15, 2008
Pharma major Zydus Cadila today said it has received approval from the US FDA to market four products, including anti-depressant Escitalopram Oxalate ... Business Standard

Aurobindo Pharma gets USFDA nod for two drugs  -  Dec 5, 2008
The company also received US Food and Drug Administration tentative approval for Escitalopram Oxalate Oral solution, used for treating depressive disorders. ... Livemint

Generic firms to gain strength from US order  -  Apr 11, 2007
Though Caraco faced infringement suit with respect to the main '712 patent on Lexapro (escitalopram oxalate), Forest and Lundbeck did not sue Caraco for ... Rediff

… Rx Completes Thin Film Escitalopram Oxalate Pilot Product Developme...  -  Aug 4, 2008
WARREN, NJ, Aug. 4 /PRNewswire/ -- MonoSol Rx, a specialty pharmaceutical company leveraging its proprietary drug delivery technology to develop thin film ... RedOrbit

Escitalopram oxalate.  -  Jul 10, 2006
Escitalopram oxalate. The FDA has approved a genetic version of Forest Laboratories' ... Escitalopram oxalate will be available in 5-, 10-, and 20-mg doses. ... $9.94 - Drug Topics - Alacra Store

… Rx Completes Thin Film Escitalopram Oxalate Pilot Product Developme...  -  Aug 4, 2008
MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Escitalopram oxalate.(NEW GENERICS)(Brief article)  -  Jul 10, 2006
The FDA has approved a genetic version of Forest Laboratories' antidepressant Lexapro. Escitalopram oxalate will be available in 5-, 10-, and 20-mg doses. $4.95 - Drug Topics - ECNext

Press Release: New Study Suggests Cymbalta(R) Reduced Depression …  -  Dec 13, 2005
Drug Administration (FDA) has approved Lexapro(TM) (escitalopram oxalate), a selective ... and support the efficacy and safety of Lexapro in the treatment ... Pay-Per-View - PR Newswire - HighBeam Research

… USFDA Approval for Escitalopram Oxalate Tablets. - PR Newswire | …  -  Jun 16, 2008
Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

International Approvals: Aricept Evess, Cipralex, Actemra  -  May 31, 2005
On May 18, the French Ministry of Health approved escitalopram oxalate tablets ... Escitalopram oxalate (Lexapro, made by Forest Laboratories, Inc., ... Medscape

Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) …  -  Nov 29, 2007
LEXAPRO is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs), pimozide, or in patients with a hypersensitivity to escitalopram oxalate ... Free with registration - PR Newswire - AccessMyLibrary.com

International Approvals: Tarceva, Cipralex, Keppra  -  Sep 26, 2005
22, the European Commission approved escitalopram oxalate (Cipralex tablets, ... Escitalopram oxalate was previously approved by France's regulatory ... Medscape

Lexapro(R) Demonstrated Significance on Prospectively Defined...  -  Dec 6, 2006
Lexapro is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs), pimozide, or in patients with a hypersensitivity to escitalopram oxalate ... Free with registration - PR Newswire - AccessMyLibrary.com

Forest Laboratories, Inc. Announces Positive Results Of LEXAPRO(R) …  -  Nov 30, 2007
Forest Laboratories, Inc. (NYSE: FRX) and H. Lundbeck A/S announced preliminary top-line results from a phase III study of LEXAPRO (escitalopram oxalate) in ... Medical News Today - Medical News Today (press release)

Press Release: Lexapro(R) Demonstrated Significance on Prospectively ...  -  Dec 6, 2006
Drug Application (sNDA) for Lexapro (escitalopram oxalate) for ... adolescents, 12 - 17 years of age. Lexapro is only the second antidepressant . ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Forest Laboratories Announces Federal Appeals Court …  -  Sep 5, 2007
Drug Application (sNDA) for Lexapro (escitalopram oxalate) for ... adolescents, 12 - 17 years of age. Lexapro is only the second antidepressant . ... Pay-Per-View - PR Newswire - HighBeam Research

Loislaw Federal District Court Opinions - FOREST LABORATORIES, INC. …  -  Jul 13, 2006
Ivax submitted ANDA 76-765 seeking approval to market generic tablets containing 5, 10 or 20 milligrams of escitalopram oxalate. (Admitted Facts at ¶ 39). ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Enjoined By Association, Supplier To ANDA Filer Subject To Injunction....  -  Sep 28, 2007
Ivax filed an ANDA for approval to market generic tablets of escitalopram oxalate (EO). EO, the oxalate salt form of escitalopram, functions as an ... Free with registration - Mondaq Business Briefing - AccessMyLibrary.com

Forest Laboratories Reports Earnings Per Share of .59 for Q2'06 -...  -  Oct 18, 2005
Net sales included $472442000 for Forest's antidepressant franchise which was comprised of $467376000 of Lexapro(R) (escitalopram oxalate), ... RedOrbit

Press Release: Study Demonstrates Lexapro(R) Significantly Improves …  -  May 7, 2008
WASHINGTON, May 7 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. announced today that study results show Lexapro (escitalopram oxalate) significantly ... Pay-Per-View - PR Newswire - HighBeam Research

Universal Forest Products Inc acquires GeoMatrix Inc - Deal Snapshot ...  -  Aug 21, 2006
United States District Court, over Forest ' s blockbuster antidepressant product, Lexapro (escitalopram oxalate). ##/#…drugs - Generics division) ... Pay-Per-View - deals - Alacra Store

Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08 …  -  Oct 16, 2007
Sales in the quarter included $559063000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, ... Free with registration - PR Newswire - AccessMyLibrary.com

Forest Laboratories, Inc. Reports Fiscal First Quarter 2006 Results.  -  Jul 19, 2005
Sales in the quarter included $461072000 for Lexapro(R) (escitalopram oxalate). Namenda(R), our NMDA receptor antagonist for the treatment of moderate to ... $4.95 - PR Newswire - ECNext

Forest Laboratories, Inc. Reports Fiscal First Quarter 2008 Earnings...  -  Jul 17, 2007
Sales in the quarter included $552313000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, ... RedOrbit

First-Time Generic Approvals: Omnicef, Lexapro, MetroLotion  -  May 26, 2005
On May 22, the FDA approved first-time generic formulations for escitalopram oxalate 5-, 10-, and 20-mg tablets (made by Ivax Corporation, a wholly-owned ... Medscape

Forest Laboratories Reports Earnings Per Share of $0.75 for Q2'07.  -  Oct 17, 2006
Sales in the quarter included $522662000 for Lexapro(R) (escitalopram oxalate), our SSRI for the treatment of depression and anxiety in adults, ... Free with registration - PR Newswire - AccessMyLibrary.com

Article: FDA tentative generics approvals--2006.(Special Report)(List)...  -  Feb 19, 2007
Escitalopram oxalate tablets, 5 mg, Teva Pharmaceuticals7/26/2006 10 mg and 20 mg USA Zaleplon capsules, 5 mg and 10 mgGenpharm Inc. 7/26/2006 Terbinafine ... Pay-Per-View - Chain Drug Review - HighBeam Research

Article: FDA Approves First Generic Lexapro - AP Online | HighBeam …  -  May 23, 2006
The agency approved 5, 10 and 20 milligram doses of the drug, also called escitalopram oxalate, for the treatment of major depression. ... Pay-Per-View - AP Online - HighBeam Research

International Approvals: Cipralex, Neupro, Relenza  -  Jan 23, 2007
January 23, 2007 — The European Commission has approved escitalopram oxalate for the treatment of obsessive-compulsive disorder, and rotigotine transdermal ... Medscape

Forest Laboratories, Inc. Reports Diluted Earnings Per Share of $0.70...  -  Jan 18, 2005
Sales in the quarter included $560640000 for Forest's antidepressant franchise which was comprised of $427118000 of Lexapro(R) (escitalopram oxalate), ... $4.95 - PR Newswire - ECNext

Article: FDA Approves First Generic Lexapro - AP Online | HighBeam …  -  May 22, 2006
The agency approved 5, 10 and 20 milligram doses of the drug, also called escitalopram oxalate, for the treatment of major depression. ... Pay-Per-View - AP Online - HighBeam Research

Article: The drugs don't work, says new antidepressants study.(News)(...  -  Feb 27, 2008
...showed that severely depressed patients treated with escitalopram oxalate showed significant improvement over placebo beginning as early as week two ... ... Pay-Per-View - Birmingham Post - HighBeam Research

ESCITALOPRAM (Oral route) - es-sye-TAL-oh-pram.(Drug overview)  -  May 1, 2007
Anyone considering the use of escitalopram oxalate or any other antidepressant in a ... Escitalopram oxalate is not approved for use in pediatric patients. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

… been granted for a first-time generic escitalopram oxalate to...  -  Aug 1, 2006
Final approval (May 22, 2006) has been granted for a first-time generic escitalopram oxalate to treat major depressive disorder. The Reference Listed Drug ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com

United States Federal Circuit Court of Appeals Reports - FOREST LAB....  -  Oct 12, 2007
...as to both Ivax and Cipla, but we modify the injunction to apply only to escitalopram oxalate. ... 10, or 20 milligrams of escitalopram oxalate ("EO"). ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw

Final US approval for Teva's generic Lexapro.  -  May 29, 2006
Teva's AB-rated escitalopram oxalate tablets are indicated for the treatment of depression. Teva is currently in patent litigation concerning this product ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Forest Laboratories, Inc. Reports Q3'07 Diluted Earnings Per Share of...  -  Jan 16, 2007
Sales in the quarter included $554964000 for Forest's antidepressant franchise which was comprised of $545855000 of Lexapro(R) (escitalopram oxalate), ... $4.95 - PR Newswire - ECNext

Forest Laboratories, Inc. Reports Q3'06 Diluted Earnings Per Share of...  -  Jan 17, 2006
Sales in the quarter included $485687000 for Forest's antidepressant franchise which was comprised of $480707000 of Lexapro(R) (escitalopram oxalate), ... $4.95 - PR Newswire - ECNext

Teva obtains 2 FDA approvals: Dostinex has US sales of $74 million a ...  -  Mar 11, 2007
Globes (Tel Aviv, Israel); May 23, 2006 ; 578 words ... ... to market its generic version of Forest Laboratories, Inc.'s Lexapro (Escitalopram Oxalate) ... Pay-Per-View - Globes - HighBeam Research

Market Live from BSE - NSE, Latest Market Commentary | Economic …  -  May 15, 2008
...while the branded sales of escitalopram oxalate tablets, an anti-depressant, was at $3 billion. Losartan potassium and nydrochiorthiazide Tablets, ... Economic Times

Article: FDA approves Teva's generic Lexapro. - Globes (Tel Aviv,...  -  May 23, 2006
Teva's AB-rated Escitalopram Oxalate Tablets are indicated for the treatment of depression. The original drug had sales of $464 million in the first quarter ... Pay-Per-View - Globes - HighBeam Research

Genetic Disorders; Company receives nonapprovable letter for panic …  -  Mar 29, 2005
...nonapprovable letter for the indication of panic disorder for Lexapro (escitalopram oxalate), a selective serotonin reuptake inhibitor antidepressant. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Caraco says FDA grants tentative approval for generic Lexapro  -  Nov 30, 2007
A) said US health regulators granted tentative approval for 5 mg, 10 mg and 20 mg of Escitalopram Oxalate tablets, a generic version of Forest Laboratories ... Reuters

RPT-UPDATE 2-US court upholds patent on Forest's Lexapro  -  Sep 6, 2007
In Wednesday's ruling, the appeals court modified the lower court's injunction so that it only applies to escitalopram oxalate, the active ingredient in ... Reuters India

A CLOSER LOOK RESEARCH FINDINGS  -  Aug 22, 2005
...citalopram hydrobromide (Celexa) or escitalopram oxalate (Lexapro). Patients with otogenic and psychogenic dizziness responded best to the medication. ... $2.95 - Milwaukee Journal Sentinel - NewsBank

Escitalopram Lowers Depression Scores in Adolescent Patients: …  -  May 12, 2008
WASHINGTON, DC -- May 12, 2008 -- Treatment with escitalopram oxalate appears to result in clinically meaningful improvements in adolescent patients with ... DG News

A CLOSER LOOK RESEARCH FINDINGS | Article from The Milwaukee …  -  Aug 22, 2005
...citalopram hydrobromide (Celexa) or escitalopram oxalate (Lexapro). Patients with otogenic and psychogenic dizziness responded best to the medication. ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research

Nation .  -  May 23, 2006
...and 20-milligram doses of the drug, called escitalopram oxalate, for treatment of major depression. In 2005 Lexapro was the No. 2 anti-depressant in the ... Milwaukee Journal Sentinel - Google News Archive

LUNESTA(R) Study Of Patients With Insomnia And Co-Morbid …  -  May 14, 2008
This 595-patient study examined the safety and efficacy of LUNESTA co-administered with escitalopram oxalate, which is commonly used in the treatment of ... Medical News Today - Medical News Today (press release)

Eli Lilly sues Sun Pharma over patent  -  Apr 2, 2007
...demanding to allow launch of its generic version of anxiety and depression drug Lexapro, known generically as escitalopram oxalate. ... Business Standard

Nation .  -  May 23, 2006
...and 20-milligram doses of the drug, called escitalopram oxalate, for treatment of major depression. In 2005 Lexapro was the No. 2 anti-depressant in the ... Milwaukee Journal Sentinel - Google News Archive

First New Treatment for Alcoholism in Ten Years, Now Available...  -  Jan 11, 2005
Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance ... RedOrbit

Forest and Cypress Announce FDA Acceptance for Review of New Drug …  -  Feb 21, 2008
Forest Laboratories' growing product line includes Lexapro® (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... marketwire.com

Forest Laboratories Receives Patent Term Extension for Lexapro.  -  Mar 2, 2006
The patent covers the composition of matter for Lexapro(R) (escitalopram oxalate) an SSRI approved for the treatment of Major Depressive Disorder and ... $4.95 - PR Newswire - ECNext

In Re Forest Laboratories, Inc., No. 05 cv. 3489 (SDNY 09/18/2006)  -  Sep 18, 2006
...which consists of the selective serotonin reuptake inhibitors ("SSRIs") Celexa (citalopram HBr) and its successor Lexapro (escitalopram oxalate). ... $2.95 - U.S. District Court, Southern District... - VersusLaw

SSRI Use in Pregnancy Linked to Risk for Pulmonary Hypertension in …  -  Jul 20, 2006
...fluvoxamine (previously marketed as Luvox by Solvay Pharmaceuticals, Inc, and now available in generic formulations); escitalopram oxalate (Lexapro, ... Medscape

New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now …  -  Mar 21, 2005
Forest Laboratories' growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the initial and maintenance ... RedOrbit

Forest And Cypress Announce Submission Of New Drug Application For …  -  Jan 2, 2008
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Medical News Today - Medical News Today (press release)

FDA: Antidepressant Use Raises Risk of Suicidal Thoughts in Young …  -  Dec 6, 2006
...patients and 11 antidepressants, including Eli Lilly's Prozac (fluoxetine), Forest's Lexapro (escitalopram oxalate) and Pfizer's Zoloft (sertraline). ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2)...  -  May 31, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Issues an Update on Replidyne, Inc.  -  Oct 24, 2006
Forest Laboratories' growing product line includes Lexapro (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of ... Free with registration - M2 Presswire - AccessMyLibrary.com

Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for...  -  Dec 18, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

New Study Compared Sexual Functioning of Patients Treated with …  -  Nov 10, 2005
...lower risk of sexual dysfunction as compared to the serotonin reuptake inhibitor (SSRI) Lexapro(R) (escitalopram oxalate) in similarly designed studies. ... DG News

Forest Announces Federal Court Upholds Lexapro(R) Patent.  -  Jul 14, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Ironwood Pharmaceuticals And Forest Laboratories Announce …  -  May 24, 2008
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Medical News Today - Medical News Today (press release)

Unsafe, Misrepresented Drugs Purchased Over the Internet: Ambien ( …  -  Feb 19, 2007
BETHESDA, MD -- February 19, 2007 -- FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications ... DG News

Data Show Sepracor's Eszopiclone Improved Insomnia in Patients with …  -  Dec 5, 2006
In this study, patients who met DSM-IV®(1) criteria for both insomnia and GAD were randomized to receive nightly Lexapro® brand escitalopram oxalate 10 mg, ... DG News

Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive …  -  Sep 4, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Forest and Cypress Announce Submission of New Drug Application for …  -  Dec 31, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Mylan Laboratories and Forest Laboratories Announce Nebivolol …  -  Jan 11, 2006
Laboratories Inc. and Its Products Forest Laboratories' (http://www.frx.com/) growing line of products includes: Lexapro(R) (escitalopram oxalate), ... Free with registration - PR Newswire - AccessMyLibrary.com

Approval: Generic escitalopram tablets.(From the FDA)(drug approval)(...  -  Jul 1, 2006
The FDA has approved a generic version of Forest Laboratories, Inc.'s selective serotonin reuptake inhibitor (SSRI) Lexapro (escitalopram oxalate), ... Free with registration - Brown University Child and Adolescent... - AccessMyLibrary.com

Product news from the 05/23/06 News Brief  -  May 23, 2006
The FDA approved the first generic version Forest Laboratories' Lexapro (escitalopram oxalate) to treat major depression, according to a posting on the ... PR Week - PRWeek

Forest Makes With Fourth Quarter and Full Year Results  -  Apr 19, 2005
Sales in the current quarter included $406432000 for Forest's antidepressant franchise which was comprised of $399381000 of Lexapro (escitalopram oxalate), ... WebProNews

Credit crunch sinks MonoSol IPO  -  Mar 30, 2008
...the Alzheimer's Disease treatment Aricept (donepezil, Eisai/Pfizer) and the antidepressant Lexapro (escitalopram oxalate, Forest Laboratories). ... In-PharmaTechnologist.com

Daiichi Sankyo and Forest Laboratories Sign Letter of Intent for Co- …  -  Aug 21, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... RedOrbit

Genetic Test May Make Antidepressants Safer  -  Oct 1, 2007
Common drugs that can have their outcomes testing for with the Mark-C test include Celexa, or citalopram hydrobromide, and Lexapro, or escitalopram oxalate. ... Ivanhoe Broadcast News

Forest Laboratories, Inc. and Gedeon Richter Announce Results of...  -  Oct 15, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Nebivolol Lowers Blood Pressure in African Americans With Stage I-II ...  -  Nov 1, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Response Submitted to FDA Approvable Letter for Hypertension …  -  May 1, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Study Results for Aclidinium Bromide, a Novel Anticholinergic,...  -  Sep 18, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Breaking Stock Alert for Friday: PLTG! October 5, 2007  -  Oct 5, 2007
Forest Laboratories (www.frx.com) is a US-based specialty pharmaceutical company with a growing line of products, including: Lexapro® (escitalopram oxalate) ... marketwire.com

Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal...  -  Jul 3, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Daiichi Sankyo and Forest Laboratories Finalize Contract for Co- …  -  Oct 12, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Patient Recruitment to Resume Without Modification of Protocol for …  -  Oct 28, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... RedOrbit

Forest Laboratories Announces Nesli Basgoz, MD Named to Board of …  -  May 18, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Replidyne and Forest Laboratories Announce FDA Acceptance for …  -  Feb 23, 2006
Forest Laboratories' (http://www.frx.com/) growing line of products includes: Lexapro(R) (escitalopram oxalate), a selective serotonin reuptake inhibitor ... RedOrbit

Stock Commentary - New York week to July 24, 2006.(financial report)(...  -  Jul 24, 2006
Forest Laboratories' stock rose 13.7% during the reported period on news of a patent victory relating to Lexapro (escitalopram oxalate). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Lundbeck and Forest Laboratories announce Lexapro patent litigation …  -  Oct 26, 2005
District of Delaware has today rescheduled the start of its pending patent litigations trial regarding Lexapro (escitalopram oxalate) from December 5, ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

Gedeon Richter and Forest Laboratories Expand Relationship with Two …  -  Nov 28, 2005
Forest Laboratories' (http://www.frx.com/) growing line of products includes: Lexapro(R) (escitalopram oxalate), an SSRI antidepressant indicated for the ... Free with registration - PR Newswire - AccessMyLibrary.com

Patient Recruitment For Desmoteplase Phase IIB/III Stroke Study DIAS...  -  Oct 26, 2006
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Medical News Today - Medical News Today (press release)

Forest Laboratories Announces Rule 144 Sale by Executive Officer.  -  Feb 12, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Free with registration - PR Newswire - AccessMyLibrary.com

Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure …  -  May 21, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... RedOrbit

Study Results For Aclidinium Bromide, A Novel Anticholinergic,...  -  Sep 19, 2007
Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment ... Medical News Today - Medical News Today (press release)

Caraco gets seventh product OK from the FDA, begins expansion  -  Dec 10, 2007
Caraco plans to market Escitalopram Oxalate tablets as a generic equivalent to Forest Laboratories Inc.'s Lexapro tablets, which had US sales of ... Crain's Detroit Business

Forest and Lundbeck announce Lexapro patent litigation trial date …  -  Oct 1, 2005
District of Delaware has rescheduled the start of its pending patent litigations trial regarding Lexapro (escitalopram oxalate) from December 5, ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com

Forest's EPS drops 5% on Microbia charge.(Forest Laboratories Inc. …  -  Oct 29, 2007
Sales in the quarter included $559.0 million for Lexapro (escitalopram oxalate), a selective serotonin reuptake inhibitor for the treatment of depression ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

Lexapro Improves Depression Symptoms In Adolescents  -  May 9, 2008
Forest Laboratories's study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to placebo treatment and ... emaxhealth.com

Brand Names/Synonyms:
escitalopram oxalate is also known by the following brand names and/or synonymsEscitalopram; Escitalopram Oxalate; Escitalopram [Inn]; Lexapro

Drug Category:
escitalopram oxalate is categorized under the following by the FDA: Antidepressive Agents, Second-Generation; Serotonin Uptake Inhibitors; ATC:N06AB10

Dosage Forms:
TABLET

Absorption:
The absolute bioavailability of citalopram is about 80% relative to an intravenous dose

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy